Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1986523Generated: November 2, 2026

Water → 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(piperazin-1-yl)-xanthine

https://huagongshe.com/reaction/1986523

Reaction equation

Participants

RoleNameHCIDCharge
ReactantWaterHCID 962—
ReactantPiperazineHCID 4837—
ReactantSodium ChlorideHCID 5234—
Reactant8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dioneHCID 24750049—
SolventDimethylformamideHCID 6228—
Product1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(piperazin-1-yl)-xanthineHCID 11374531—

Reaction Conditions

Temperature200 °C

Reaction Steps

A mixture of 300 mg of 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine and 290 mg of piperazine in 5 ml of N,N-dimethylformamide is heated at 200° C. for 5 min in a microwave oven. After cooling to room temperature, the reaction mixture is treated with water and saturated sodium chloride solution and extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried over magnesium sulphate and concentrated. The solid flask residue is triturated with diethyl ether, filtered off with suction and dried at 45° C. in a circulating air drying oven.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07550455B2
Source datasetuspto-grants-2009_06
ORD IDord-4b9f201103714d1f8ff6fb7085877fc7
Source noteuspto-grants-2009_06